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Conclusion: CAE is rare in patients presenting with STEMI. CAE as
culprit lesion is rare in women and obese. Dyslipidemia was most
commonly seen in association with CAE, followed by hyperten-
sion, smoking and DM. Majority of patients with ectatic arteries
had single-vessel disease. PCI could be performed inmajority (2/3)
of these patients and they have good clinical outcome in terms of
MACE at one year follow up.
Coronary artery disease in women: A gender
comparative study of angiographic profiles in a
tertiary care centre
Sanjay Gidwani, Arkar Moe, Thant Zaw Maung, S. Sushmita,
C. Sridevi
CARE Hospital e CARE Foundation, India
Aim: To study the coronary angiographic profile in women in
comparison to men.
Material and Methods: The results of angiography performed over
a period of three months were evaluated. The results were
grouped into female and male data and the demography, risk
factors, angiographic anatomy and advice were compared.
Results: 395 females and 462 males underwent angiography dur-
ing this period.
-Both groups were divided according to age into three groups <
40 years ,40 to 65 years ,> 65 years -The number ofmales aged <
40 was higher than females in the same group(9.3%vs 4% p
value 0.008)
-Diabetics were higher in males (44.8 %vs. 45.5 % p value 0.92)
-Hypertensionwasmore among females (69.6 % females vs. 56.7
%p value0.12)
-Smoking was significantly higher inmales( 21% vs. 1.5% p value
0.005)
-The number of females with family history of coronary artery
disease was marginally higher (8.65% vs. 9.1% p value 0.88)
-The tread mill test as indication for coronary angiography was
higher amongst females than males (16.6 % in males vs. 26% in
females p value 0.25)
-Unstable angina with NSTMI was more frequent amongst
males than females(12.79 % vs. 4.0% p value 0.0001)
-The number ofmaleswith triple vessel diseasewas higher than
females (27.92 % vs. 14.17 % p value of 0.001)
-The number of patients undergoing CABG was higher in males
-The number of females with normal coronary anatomy was
higher than males (19.8%vs 11.6% p value of 0.06)
-Number of males with triple vessel disease was high amongst
males with positive tread mill test(15.5 %vs 8.4 % p value 0.01)
Conclusions: TMT as an indicator for angiography was more in
common in females and unstable angina in males. TMT positive's
with normal coronary anatomy was more in females. Females
were less likely advised CABG. Females in the age group of <40
was less compared to males. Diabetics were more in males and
hypertension was common in females.
Prevalence and impact of metabolic syndrome on
hospital outcomes in acute myocardial infarction
G.S. Gireesh, A. George Koshy
Government Medical College, Thiruvananthapuram, India
Background: The National Cholesterol Education Program’s Adult
Treatment Panel III report (ATP III) identified the metabolic syn-
drome as a multiplex risk factor for cardiovascular disease (CVD)
that is deserving of more clinical attention.
Aims and objectives: To assess the difference in in-hospital out-
comes in patient with acute coronary syndrome e ST elevation
myocardial infarction (STEMI) who have metabolic syndrome as
compared with those who do not have metabolic syndrome.
Methods: Retrospective analysis of ACS registry data of 427
consecutive patients admitted in ICCU, Medical College, Trivan-
drum with acute myocardial infarction from September 2013 to
February 2014.
Results: The mean age group of the study cihort was 57± 11yrs.
Though less in sample size females (48.4%) had a higher incidence
of metabolic syndrome.Hypertension was identified as the com-
monest risk factor (93.6%) among the 5 risk factors for metabolic
syndrome.The mortality rate was 9.5%, with no major difference
in the outcome data between the two groups.
Conclusions: Though metabolic syndrome is recognized as a
major cardiovascular risk factor and determinant of adverse
outcomes, in the present study, no major statistical difference
among the two cohorts with and without metabolic syndrome
were identified.
Rate of reperfusion in patients of ST-elevation MI
after window period; comparison with
percutaneous angioplasty: a study of 126
consecutive patients
R.K. Gujju, V. Sharma, A.P. Arora, L.C. Gupta
National Heart Institute, New Delhi, India
Background: The most important part of management of ST
elevation myocardial infarction is to enable myocardial blood
supply as early as possible. The twomainmodality of treatment in
practice now-a-days is to procure myocardial reperfusion by
either thrombolytic therapy or percutaneous coronary interven-
tion (PCI).
Aims: In the present study, we used three non-invasive markers
and finally coronary angiography as a marker to assess coronary
artery patency or ongoing ischemia after revascularization.
Methods: A total of 126 patients with a diagnosis of acute ST
elevation myocardial infarction were investigated. Among them
66 patients underwent primary PCI (Group I) and 60 patients were
treated with thrombolytic therapy with tenectaplase (Group II).
Reperfusion was assessed by clinical disappearance of chest pain,
early peak creatinine kinase (CK) activity in < 12 hours after the
start of thrombolysis or PCI, > 50% reduction in ST segment
elevation, occurrence of reperfusion arrhythmia within first 24
hours of reperfusion therapy. Thrombolysis in Myocardial
infarction Grade II or III flow after reperfusion was assessed by
coronary angiography in all of the patients.
Results: There was no statistically significant difference between
the two groups in the frequency of reperfusion arrhythmias, ST
segment regression in ECG or early peak CK level. Although
angiographic vessel patency was slightly higher in patients un-
dergoing PCI (97.6% vs. 96.2%, p ¼ 0.08), but complication rate like
periprocedural bleeding (28.7% vs. 12.4%, p ¼ 0.06), cardiac
arrhythmia (27.3% vs. 13.4%, p ¼ 0.07) and myocardial rupture
(2.5% vs. 0.1%, p ¼ 0.06) are significantly higher in the PCI group.
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Conclusion: Our study suggests that thrombolytic therapy is a
reasonable option for reperfusion therapy even in case of ST
elevation MI presenting after window period, with a lower rate of
periprocedural complication, as compared to PCI.
A study of aspirin plus clopidogrel versus aspirin
alone on saephenous vein graft patency after
coronary artery bypass graft surgery e an
angiographic follow-up after three months
O.S. Thopte, S.P. Patil, R.S. Deshmukh
Sri Sathya Sai Institute of Higher Medical Sciences, Prashanthigram, AP,
India
Background: The co-administration aspirin-clopidogrel results in
enhancement of platelet inhibition and would improve outcomes
after CABG in terms of graft patency and major adverse cardio-
vascular events.
Objectives: The objective of this study was to examine the clinical
efficacy of clopidogrel treatment on saphenous vein graft patency,
incidence of major adverse cardiovascular events and safety
following CABG at the end of 3 months.
MethodsandResults: In this study, 74patientsundergoing coronary
arterybypassgraftingwithSVGswere randomized toreceiveaspirin
150 mg plus clopidogrel 75 mg daily or aspirin 150 mg plus placebo
daily for 3months. The primary outcomewas saphenous vein graft
patency as determined coronary angiography at 3 months. Sec-
ondary outcomes were major adverse cardiovascular events, and
major bleeding. At the end of 3 months coronary angiography was
performed in 66 patients (89.1%). Overall 3month SVG graft patency
was 95.2% in the aspirin-clopidogrel group compared with 82.1% in
the aspirin-placebo group (P¼0.007), and LIMApatencywas 97.1% in
the aspirin-clopidogrel group versus 96.9% in the aspirin-placebo
group (P¼1.000). Freedomfrommajor adverse cardiovascular events
at 3 months was similar for the 2 groups. The incidence of major
bleeding at 3 months was similar for the 2 groups (8.8 versus 6.25%,
aspirin-clopidogrel versus aspirin-placebo, P¼1.000).
Conclusions: Compared with aspirin monotherapy, the combi-
nation of aspirin plus clopidogrel did significantly improve SVG
patency 3 months after coronary artery bypass grafting without
increasing the risk of major bleeding complications.
Demographic, clinical profile and intermediate-
term clinical outcomes of ostial and ostioproximal
lesion stenting at a tertiary care referral institute
in South India
P.K. Dash, B. Barooah, Prayaag Kini, Sola S.R. Varyani
Dept of Cardiology, SSSIHMS, Whitefield, Bangalore, India
Background: Ostial and ostioproximal stenting have traditionally
been considered complex interventions and higher rate of reste-
nosis was seen in the BMS era. After the advent of DES, though
restenostic rates have come to single figures, most authoritative
guidelines recommend surgical recourse for ostial lesions due to
higher rates of reinterventions and TLR. This retrospective anal-
ysis was conducted at a tertiary care referral centre in South India
to determine intermediate term clinical outcomes and rates of
clinical restenosis at 9th-month follow up.
Methods: Patients who serially underwent coronary intervention
for ostial and/or ostioproximal lesions between Jan 1, 2011 and
Dec 31, 2012 at SSSIHMS Bangalore were studied for their symp-
toms, functional status, comorbidities and echocardiographic
parameters, including LVEF. The demographic parameters
including the age, gender and risk factors, the clinical presenta-
tion and profile, as also the angioplasty details including the stent
deployment data were collected at baseline. At 9th month follow-
up a clinical assessment and echocardiographic follow-up was
conducted.
Results: 72 patients (males¼44, females¼28) underwent PCI in the
above period, of whom 9th month clinical and echocardiographic
follow-up was available in 47 patients (67.4 %). The arteries
intervened upon in ostial location were: LAD in 42, RCA in 23, LCX
in 5, LPDA in 1,and major OM in 1.Two patients had combined
proximal RCA and op LAD stenting. Implanted stents were: DES:
45 and BMS 32 (mainly due to compelling indications). Average
stent size was 3.15 ± 1.35 mm, length-21 mm ± 2.1 mm. In all
LMCA to opLAD stenting proximal flaring of the stent was
performed.
On follow-up at 9 months : in the 47 (36/ 54 ACS : 11/18 SIHD),
patients on follow-up, good compliance with medication was
noted. At least 4 patients had recurrent ACS and underwent a
repeat stenting at our Institute and two definite stent thrombosis
occurred during hospital course.6 patients were referred for CABG
due to ISR and recurrence of symptoms, of whom poor drug and
DAPT compliance was noted in 3 patients. 8 of these 12 patients
had stenting from the initial ACS arm. Excluding these, therefore
35 patients reported as being asymptomatic and return of
acceptable quality of life .Of the 36 ACS ,21 ACS had no change or
fall in LVEF but angina grade improved by at least one grade, in 15
LVEF improved by at least 5 % with improvement in angina,( P
¼0.069 ). The delay in referral from occurrence of ACS to perfor-
mance of PCI could explain the lack of improvement in ACS pa-
tients undergoing ostial PCI.7/11 patients with SIHD had a
preserved LVEF and improvement in angina, 4 patients with SIHD
continued to have symptoms of lower grade of angina and were
managed medically ( P<0.01 for improvement after PCI).
Conclusion: We inferred from our analysis that ostial stenting in
ACS led to improvement in anginal symptoms at intermediate
term follow-up with no significant objective improvement in LVEF
especially in patients with DM; however in SIHD significant
improvement in clinical symptoms with less recurrent events
(less clinical restenosis) supports the feasibility of ostial stenting
in this situation.
Prevalence and association of major coronary risk
factors with CAD: Single centre study
K.A. Sambasivam, S. Natarajan, P.R. Vydianathan,
Rajpal K. Abhaichand, P.I.S. Chakravarthi, Bivin Wilson,
J.K. Periasamy, V. Nithya
G. Kuppuswamy Naidu Memorial Hospital, Coimbatore, India
Background: Different studies in our country on risk factor prev-
alence and association with CAD have shown varying picture. No
major large scale study has been done in this part of the country.
Methods: This is a retrospective cross sectional observational
study. We collected data from inpatient and outpatient records
between 1995 and 2010. Data were collected with respect to
presence of DM, HT, Smoking and levels of TC, HDL, LDL & TG and
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